RNA, U2 small nuclear 62, pseudogene (RNU2-62P)

RNA, U2 small nuclear 62, pseudogene (RNU2-62P) is classified as a pseudogene and part of the large family of U2 small nuclear RNAs in the human genome[1]. U2 small nuclear RNAs (snRNAs) are typically integral for pre-mRNA splicing as part of the spliceosome, but pseudogenes like RNU2-62P are generally nonfunctional and do not encode active RNA or protein products[1]. There is no evidence that RNU2-62P is a therapeutic or functional molecular target. No biological function, interaction with drugs, nor direct association with disease has been documented for this specific pseudogene. Pseudogenes may arise from duplication or retrotransposition events but typically lack the necessary regulatory or coding features for gene product expression, and are therefore not considered classic therapeutic targets[1]. Assessment: - This gene is not considered a valid molecular target (therapeutic or otherwise), and there is no known relevance to drug development or disease. - The name and abbreviation are correct for a pseudogene, but there is no evidence of molecular function, disease role, or targeting potential. - The query is for a non-coding, non-functional pseudogene, not an active molecular target[1].

Other names

RNU2-62PRNA, U2 small nuclear 62, pseudogene